| PUBCHEM ID |
72734356
|
| UNII |
9JX5MZ1I64
|
| Preferred Term |
CABAZITAXEL ACETONE
|
| CAS |
1426815-65-7
|
| INCHIKEY |
JXGFNOAMBPABCK-JVXKREHESA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC(C)(C)OC(N[C@@H]([C@@H](C(O[C@H](C1)C(C)=C([C@@H](C([C@@](C)([C@@H](C[C@@H]2OC3)OC)[C@@H]([C@H]4OC(c5ccccc5)=O)[C@]23OC(C)=O)=O)OC)C(C)(C)[C@@]14O)=O)O)c1ccccc1)=O
|
| Total Surface Area |
600,78
|
| Relative PSA |
0,28773
|
| TPSA |
202,45
|
| cLogS |
-6,067
|
| MW |
835,941
|
| cLogP |
3,4648
|
| H-Acceptors |
15
|
| H-Donors |
3
|
| Ro5 violations |
2
|
| Druglikeness |
-55,66
|
| DrugScore |
0,145579804714633
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,5592
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,6413
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,7001
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,6378
|
| Carcinogenicity (Three-class) |
Non-required
|
